Who was Barbara Mitchell?
  1. patented medicine
  2. patented medicine

patented medicine

Août 17, 2022 1:48PM

Pandemic showed that Canada needs a thriving biopharmaceutical industry
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Pandemic showed that Canada needs a thriving biopharmaceutical industry

Government policies and regulations have created an environment hostile to research and innovation.

Étiquettes:
pmprb, canadian drug prices, patented medicine, patented drugs, pharmaceutical, drug regulations
Août 16, 2022 1:00AM

An Evaluation of the Proposed PMPRB Amendments
Kristina M.L. Acri, née Lybecker
Printer-friendly version
An Evaluation of the Proposed PMPRB Amendments
Étiquettes:
pmprb, canadian drug prices, patented medicine, patented drugs, pharmaceutical, drug regulations
Septembre 17, 2018 10:43AM

Ottawa's planned changes to review process will limit patient access to lifesaving drugs
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Ottawa's planned changes to review process will limit patient access to lifesaving drugs

Profit incentivizes innovation and helps fund research and development.

Étiquettes:
patented medicine, patented prescription drugs, patented drugs, prescription drug patents, pharmaceutical patents, access to new drugs, access to new medicine
Août 31, 2018 9:54AM

Increasing barriers for drug manufacturers may ultimately hurt patients

Dr. Nigel Rawson
Printer-friendly version
Increasing barriers for drug manufacturers may ultimately hurt patients

Ottawa’s changes may delay the launch of new innovative medications in Canada.

Étiquettes:
drug patents, access to medicines, regulating new medicine, patented medicine, patented prescription drugs
Juillet 20, 2018 1:00AM

Implications of the proposed changes to Canada's pharmaceutical pricing regulations
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Implications of the proposed changes to Canada's pharmaceutical pricing regulations
Étiquettes:
canadian drug prices, patented medicine, pmprb, drug patents, drug patent regulations
Juillet 6, 2017 2:07PM

Ottawa’s proposed changes to review board will reduce access to prescription drugs
Dr. Nigel Rawson, Bacchus Barua
Printer-friendly version

Delay or denial of access to life-saving drugs is a potential death sentence.

Étiquettes:
prescription drug prices, prescription drug costs, patented medicine, medications, biologics, generic prescription drugs, new prescription drugs, access to new medicine
Avril 25, 2013 2:00AM

Federal Delays in Approving New Medicines 2013
Bacchus Barua, Nadeem Esmail
Printer-friendly version
Étiquettes:
new medicine, drug approval process, canadian drug approval, health canada, wait for new medicine, pharmaceutical, patented medicine